Actively Recruiting
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Led by Glaukos Corporation · Updated on 2026-03-30
510
Participants Needed
1
Research Sites
314 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
CONDITIONS
Official Title
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Ocular Hypertension or Open-Angle Glaucoma in the study eye
You will not qualify if you...
- Prior incisional glaucoma surgery in the study eye
- Prior argon laser trabeculoplasty (ALT) in the study eye
- Prior minimally invasive glaucoma (MIGS) surgery in the study eye
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Glaukos Investigative Site
Dothan, Alabama, United States, 36301
Actively Recruiting
Research Team
S
Study Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here